News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Frazier Life Sciences VIII, L.P.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/09/2022 |
SC 13D/A
| Frazier Life Sciences VIII, L.P. reports a 14.6% stake in Arcutis Biotherapeutics, Inc. |
| 02/15/2022 |
SC 13D/A
| Frazier Life Sciences VIII, L.P. reports a 10.8% stake in Alpine Immune Sciences, Inc. |
| 01/28/2022 |
SC 13G/A
| Frazier Life Sciences VIII, L.P. reports a 8.4% stake in Sierra Oncology, Inc. |
| 09/21/2021 |
SC 13D/A
| Frazier Life Sciences VIII, L.P. reports a 10% stake in Alpine Immune Sciences, Inc. |
| 05/12/2021 |
SC 13D/A
| Frazier Life Sciences VIII, L.P. reports a 16.9% stake in Arcutis Biotherapeutics, Inc. |
| 05/04/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/09/2021 |
SC 13D/A
| Frazier Life Sciences VIII, L.P. reports a 21.7% stake in Arcutis Biotherapeutics, Inc. |
| 02/04/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 10/06/2020 |
SC 13D/A
| Frazier Life Sciences VIII, L.P. reports a 24.1% stake in Arcutis Biotherapeutics, Inc. |
| 07/30/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 06/18/2020 |
SC 13D/A
| Frazier Life Sciences VIII, L.P. reports a 2.9% stake in Entasis Therapeutics Holdings Inc. |
| 04/29/2020 |
SC 13D/A
| Frazier Life Sciences VIII, L.P. reports a 2% stake in Sierra Oncology, Inc. |
| 03/23/2020 |
SC 13D/A
| Frazier Life Sciences VIII, L.P. reports a 7.9% stake in Entasis Therapeutics Holdings Inc. |
| 02/07/2020 |
SC 13D
| Frazier Life Sciences VIII, L.P. reports a 27.7% stake in Arcutis Biotherapeutics, Inc. |
| 01/16/2020 |
SC 13D/A
| Frazier Life Sciences VIII, L.P. reports a 7.1% stake in Aptinyx Inc. |
| 01/13/2020 |
SC 13D/A
| Frazier Life Sciences VIII, L.P. reports a 9.8% stake in Entasis Therapeutics Holdings Inc. |
| 10/09/2018 |
SC 13D
| Frazier Life Sciences VIII, L.P. reports a 10.3% stake in Entasis Therapeutics Holdings Inc. |
| 07/28/2017 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
|
|